{"title":"Tick-killing pill shows promising results in human trial","link":"https://arstechnica.com/?p=2010699","date":1710587804000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2024/03/tick-800x533.jpg\" alt=\"A tick on a human\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2024/03/tick.jpg\">Enlarge</a> (credit: <a href=\"https://www.gettyimages.com/detail/photo/infected-female-deer-tick-on-hairy-human-skin-royalty-free-image/1162834740\">Ladislav Kubeš</a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>If you have a dog or cat, chances are you’ve given your pet a flavored chewable tablet for tick prevention at some point. What if you could take a similar pill to protect yourself from getting <a href=\"https://www.wired.com/story/ticks-are-spreading-in-the-us-and-taking-new-diseases-with-them/\">Lyme disease</a>?</p>\n<p>Tarsus Pharmaceuticals is developing such a pill for humans—minus the tasty flavoring—that could provide protection against the tick-borne disease for several weeks at a time. In February, the Irvine, California–based biotech company <a href=\"https://ir.tarsusrx.com/news-releases/news-release-details/tarsus-announces-positive-topline-results-carpo-phase-2a-proof\">announced results from a small, early-stage trial</a> showing that 24 hours after taking the drug, it can kill ticks on people, with the effects lasting for up to 30 days.</p>\n<p>“What we envision is something that would protect you before the tick would even bite you,” says Bobby Azamian, CEO of Tarsus.</p></div><p><a href=\"https://arstechnica.com/?p=2010699#p3\">Read 16 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=2010699&amp;comments=1\">Comments</a></p>","author":"WIRED","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"997c643f3afe341fea302b623003dd4a17ba01ac0484aa2841476b5d044f1362","category":"Tech"}